Left Top Image Right Top Image

Saturday, February 25, 2012

Infinata's BioPharm Clinical™ Incorporates Massive New Data Sets to Enhance Trial Analytics Throughout EMEA

by Mann 0 comments

Share this post:
Design Float | StumbleUpon | Reddit

The industry's most comprehensive solution for global study feasibility and site selection support just got better. Infinata's BioPharm Clinical™ has integrated massive data sets from EudraCT to complement existing sources (including ten international regulatory institutions) to provide subscribers with full access to all 16,500 trials throughout EMEA.

This significant influx of data will further enable subscribers to:

•Search an enormous pool of EMEA trials by phase, endpoints, inclusion/exclusion criteria, sites and more
• Generate custom reports to capture a complete picture of clinical activity in EMEA by indication and country


"We are excited to increase our European clinical coverage for our valued clients," said Ruth McHenry, Managing Director of Infinata. "The most important benefits will be realized in our thorough analytics section with expanded analysis of European registered trials."

Read More

Comments 0 comments

Subscribe feeds via e-mail
Subscribe in your preferred RSS reader
  • Add to yahoo reader
  • Subscribe in NewsGator Online
  • Add to Google Reader or Homepage
  • Subscribe in Bloglines
  • Add to netvibes

Subscribe feeds rss Recent Entries

Categories

Sponsored Links

Subscribe feeds rss Recent Comments

Technorati

Technorati
My authority on technorati
Add this blog to your faves

Live Traffic